Plain-English translation of NCT05086497 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Optune, an electrical therapy treatment for glioblastoma (a serious type of brain cancer). The study compares two ways of planning where to place the treatment patches: the standard method using regular MRI scans, or a newer method using advanced MRI scans that show more detail about where cancer is spreading in the brain.
Doctors want to know if using more detailed brain imaging helps them position the electrical therapy patches in the best possible location, so the treatment can reach more cancer cells and work more effectively.
You likely qualify if…
You likely don't qualify if…
You will receive Optune as part of your regular cancer care, which involves wearing electrode patches on your scalp that deliver electrical pulses to help fight the cancer. The main difference is that your treatment patches will be positioned using either standard brain imaging or advanced brain imaging techniques. You'll be monitored during the study to see how well the treatment works and how it affects your quality of life.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States